Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc. (NEUP) shows 2 recent insider filings from 1 insider, with all of them on the buy side. With $3.3M in purchases and $0 in sales, the recent tape is heavily weighted toward buying (a net purchase of $3.3M). Lynx1 Capital Management LP (10% Owner) is the most active by dollar volume, and the single largest transaction was $3.3M by Lynx1 Capital Management LP. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.